首页> 外文期刊>International journal of molecular medicine >Application of a proteomic approach to identify proteins associated with primary graft non-function after liver transplantation
【24h】

Application of a proteomic approach to identify proteins associated with primary graft non-function after liver transplantation

机译:蛋白质组学方法在鉴定肝移植后与原发性移植物无功能相关的蛋白质中的应用

获取原文
           

摘要

Primary graft non-function (PNF) is a rare, life-threatening complication of liver transplantation. Increasing use of extended criteria donor pools and high-risk recipients seem to influence the incidence of PNF. Primary failure is associated with high patient morbidity and inferior graft survival. The only available treatment for PNF is emergency hepatic retransplantation, which is also correlated with significant morbidity and mortality. Therefore, researchers are working to identify risk factors of diagnostic value to prevent PNF. The current study attempted to explore liver proteomic patterns in patients with PNF. Using two-dimensional gel electrophoresis and liquid chromatography-mass spectrometry (LC-MS), we compared liver protein homogenates from 3 patients with PNF to those obtained from 6 healthy liver samples to identify potential new biomarkers of PNF. Our comparisons revealed 21 proteins with differential expression (13 upregulated and 8 downregulated). Most of these proteins are involved in energy metabolism, lipid metabolism, peptide cleavage, cell differentiation, and apoptosis. Although none of these proteins appeared more than once in separate analyses, this preliminary study shows that two-dimensional gel electrophoresis and LC-MS may allow identification of characteristic proteins to be used as biomarkers of a life-threatening complication of liver transplantation. Larger-scale analyses could improve patient care by finding suitable prognostic and therapeutic options. These data represent the first global proteomic approach to study PNF.
机译:原发性移植物非功能性(PNF)是罕见的危及生命的肝移植并发症。越来越多地使用扩大标准的供体库和高风险的受者似乎会影响PNF的发生。原发性衰竭与较高的患者发病率和较差的移植物存活率相关。 PNF唯一可用的治疗方法是紧急肝再移植,这也与明显的发病率和死亡率相关。因此,研究人员正在努力确定具有预防PNF的诊断价值的危险因素。当前的研究试图探索PNF患者的肝蛋白质组学模式。我们使用二维凝胶电泳和液相色谱-质谱(LC-MS),比较了3例PNF患者的肝蛋白匀浆与6例健康肝样品中的肝匀浆蛋白,以确定潜在的PNF新生物标志物。我们的比较揭示了21种具有差异表达的蛋白(13个上调和8个下调)。这些蛋白质大多数涉及能量代谢,脂质代谢,肽裂解,细胞分化和凋亡。尽管这些蛋白质在单独的分析中都没有出现过一次以上,但这项初步研究表明,二维凝胶电泳和LC-MS可以鉴定特征性蛋白质,将其用作威胁生命的肝移植并发症的生物标志物。大规模分析可以通过找到合适的预后和治疗选择来改善患者护理。这些数据代表了研究PNF的第一个全球蛋白质组学方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号